Stock disconnect triggers investor exodus from CStone Pharma
The share price fell nearly 40% in a week after the drugs company was dropped from a scheme allowing mainland investors to trade Hong Kong-listed stocks Key Takeaways: CEO Jason…
Yonghe Medical’s share repurchase gets results, but can’t hide a receding profit line
A big run-up in wages and marketing costs related to its aggressive expansion pulled the hair restoration company into the red in the first half of this year Key Takeaways:…
FAST NEWS: Yonghe Medical swings to red, sending shares to new low
The latest: Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) issued a profit warning last Friday, saying it expects a net loss of about 240 million yuan ($33.6 million) in the first half…
FAST NEWS: Yonghe Medical Expects Half-year Profit To Plunge 50% to 73%
The latest: Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) issued a profit warning last last week, saying it expects a net profit of about 11 million yuan ($16.2 million) to…
FAST NEWS: Yonghe Medical Grows Hair Care Business, But Profit Falls
The latest: Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) said late on Thursday that its profit fell 26.4% last year to 120 million yuan ($18.9 million), equal to…
Recent Articles
RELATED ARTICLES
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK -
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
-
Hong Kong’s Café de Coral takes go-slow approach to Mainland dining market
0341.HK
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
CIMC Vehicles heads for Hong Kong exit ramp via share buyback
1839.HK 301039.SHE
- Charged up by new investor BYD, BaTeLab cleared for IPO
